- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02954809
Effects of Bright Light Therapy on Fatigue, Sleep and Circadian Activity Rhythms in Lung Cancer Survivors
November 3, 2016 updated by: State University of New York at Buffalo
The purpose of this study is to determine the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
A randomized controlled trial to test the effects of morning bright light therapy on fatigue, sleep disturbances, and circadian activity rhythms in lung cancer survivors.
Study Type
Interventional
Enrollment (Anticipated)
14
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Buffalo, New York, United States, 14214
- Recruiting
- Suny University at Buffalo
-
Contact:
- Carleara Ferreira da Rosa Silva, MS, RN
- Phone Number: 716-829-3494
- Email: carleara@buffalo.edu
-
Principal Investigator:
- Carleara Ferreira da Rosa Silva, MS, RN
-
Principal Investigator:
- Grace E Dean, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Stage I-III Non-small cell lung cancer survivors
- Must be at >6-weeks and < 3 years post-surgical resection
- Must have diagnosis fatigue and/or sleep disturbances
Exclusion Criteria:
- Individuals clinically unstable.
- Mania, Bipolar disease or seizure disorder
- Macular degeneration or glaucoma.
- Currently receiving chemotherapy or radiation.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Experimental
Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.
|
Exposure to morning bright light therapy delivered with Green-Blue Re-Timer glasses for 30 minutes in the morning during one week.
|
Active Comparator: Attention Control
Exposure to dim light delivered with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.
|
Exposure to dim light with Red-Yellow Re-Timer glasses for 30 minutes in the morning during one week.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in fatigue symptoms with Fatigue Severity Index from pre-test to post-test
Time Frame: 5 weeks
|
Comparison of fatigue severity from pre-test to post-test.
|
5 weeks
|
Change in sleep quality with the Pittsburgh Sleep Quality Index from pre-test to post-test
Time Frame: 5 Weeks
|
Comparison of Sleep Quality from pre-test to post-test.
|
5 Weeks
|
Changes in insomnia with Insomnia Severity Index from pre-test to post-test
Time Frame: 5 weeks
|
Comparison of insomnia from pre-test to post-test.
|
5 weeks
|
Change in circadian activity rhythms with actigraphy from pre-test to post-test
Time Frame: 5 weeks
|
Circadian Activity Rhythms will be assessed with actigraphy during the 5-week time frame.
|
5 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessement of chronotype with the Morningness versus Eveningness Questionnaire
Time Frame: 1 day
|
Chronotype will be assessed at baseline for a descriptive analysis.
|
1 day
|
Assessment of Environmental light with actigraphy (Actiwatch Spectrum Respironics)
Time Frame: 5 weeks
|
Exposure to environmental light will be assessed at pre-test, intervention and post-test for a descriptive analysis
|
5 weeks
|
Changes in Quality of Life with theFunctional Assessment of Cancer Therapy - Lung
Time Frame: 5 weeks
|
Quality of Life will be assessed before, during, and after the intervention.
|
5 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of Visual acuity with the Snellen visual acuity chart
Time Frame: 5 weeks
|
Visual acuity data will be collected and save for safety purposes only at pre-test and post-test.
|
5 weeks
|
Assessment of daytime sleepiness with the Epworth Sleepiness Scale
Time Frame: 5 weeks
|
Daytime Sleepiness will be assessed for safety purposes only at pre-test, intervention and post-test.
Individuals with high daytime sleepiness and/or at risk of falling asleep while driving or performing hazardous activities will be referred out to primary care
|
5 weeks
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Dean GE, Redeker NS, Wang YJ, Rogers AE, Dickerson SS, Steinbrenner LM, Gooneratne NS. Sleep, mood, and quality of life in patients receiving treatment for lung cancer. Oncol Nurs Forum. 2013 Sep;40(5):441-51. doi: 10.1188/13.ONF.441-451.
- Ancoli-Israel S, Rissling M, Neikrug A, Trofimenko V, Natarajan L, Parker BA, Lawton S, Desan P, Liu L. Light treatment prevents fatigue in women undergoing chemotherapy for breast cancer. Support Care Cancer. 2012 Jun;20(6):1211-9. doi: 10.1007/s00520-011-1203-z. Epub 2011 Jun 11.
- Jeste N, Liu L, Rissling M, Trofimenko V, Natarajan L, Parker BA, Ancoli-Israel S. Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy. Qual Life Res. 2013 Aug;22(6):1239-44. doi: 10.1007/s11136-012-0243-2. Epub 2012 Aug 3.
- Ancoli-Israel S, Liu L, Rissling M, Natarajan L, Neikrug AB, Palmer BW, Mills PJ, Parker BA, Sadler GR, Maglione J. Sleep, fatigue, depression, and circadian activity rhythms in women with breast cancer before and after treatment: a 1-year longitudinal study. Support Care Cancer. 2014 Sep;22(9):2535-45. doi: 10.1007/s00520-014-2204-5. Epub 2014 Apr 15.
- Redd WH, Valdimarsdottir H, Wu LM, Winkel G, Byrne EE, Beltre MA, Liebman ES, Erazo T, Hayes JA, Isola L, Scigliano E, Meschian Y, Lutgendorf S, Ancoli-Israel S. Systematic light exposure in the treatment of cancer-related fatigue: a preliminary study. Psychooncology. 2014 Dec;23(12):1431-4. doi: 10.1002/pon.3553. Epub 2014 May 2. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2016
Primary Completion (Anticipated)
May 1, 2017
Study Registration Dates
First Submitted
October 26, 2016
First Submitted That Met QC Criteria
November 1, 2016
First Posted (Estimate)
November 3, 2016
Study Record Updates
Last Update Posted (Estimate)
November 4, 2016
Last Update Submitted That Met QC Criteria
November 3, 2016
Last Verified
October 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 030-702786
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fatigue
-
Bakulev Scientific Center of Cardiovascular SurgeryFoundation for the Support of Physical Culture and Sports BECOME A CHAMPION; Autonomous Non-Profit organization of additional education sports school BECOME A CHAMPIONNot yet recruitingEfficacy, Self | Fatigue, Mental | Fatigue; Muscle, Heart | Fatigue; CombatRussian Federation
-
Universita di VeronaUniversity of Southern CaliforniaCompletedDiet, Healthy | Fasting | Fatigue, Mental | Fatigue; Muscle, HeartItaly
-
University of ZurichRecruitingVocal FatigueSwitzerland
-
KU LeuvenCompleted
-
Société des Produits Nestlé (SPN)Maastricht University Medical CenterCompleted
-
University of Applied Sciences for Health Professions...University of Wisconsin, MilwaukeeCompleted
-
Taoyuan General HospitalCompleted
-
Alaa Yousri Mahmoud AtiaUnknownMuscle FatigueEgypt
-
University Hospital, Clermont-FerrandLaboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques...CompletedNeuromuscular FatigueFrance
-
Central Hospital, Nancy, FranceUniversity of Lorraine; Institut National de Recherche et de Sécurité, Nancy...Unknown
Clinical Trials on Morning bright light therapy
-
Portland VA Medical CenterOregon Health and Science UniversityRecruitingBrain Injuries, Traumatic | Post-traumatic Stress DisorderUnited States
-
VA Office of Research and DevelopmentRecruiting
-
Rush University Medical CenterRecruitingSleep | Circadian Rhythm | Adolescence | Chronobiology | LightUnited States
-
Guangzhou Psychiatric HospitalUnknownDepressive Disorder | Light TherapyChina
-
Rush University Medical CenterCompleted
-
VA Office of Research and DevelopmentRecruiting
-
Maimonides Medical CenterFoundation for Prader-Willi ResearchRecruitingBody Weight | Hyperphagia | Prader-Willi Syndrome | Mood | Behavior | Excessive Daytime SleepinessUnited States
-
Sunnybrook Health Sciences CentreCompletedMajor Depressive Disorder | Seasonal Affective Disorder | NeuroimagingCanada
-
Hospital Authority, Hong KongUnknown
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingBladder Carcinoma | Kidney Carcinoma | Prostate Carcinoma | Genitourinary System NeoplasmUnited States